Published in Cerebrovasc Dis on April 16, 2009
Post-stroke epilepsy in young adults: a long-term follow-up study. PLoS One (2013) 0.98
Pivotal roles of monocytes/macrophages in stroke. Mediators Inflamm (2013) 0.92
Novel antiplatelet agents in the prevention of cardiovascular complications--focus on ticagrelor. Vasc Health Risk Manag (2010) 0.92
An eicosanoid-centric view of atherothrombotic risk factors. Cell Mol Life Sci (2012) 0.84
Emerging antiplatelet agents, differential pharmacology, and clinical utility. J Blood Med (2010) 0.83
Comparison of the new ASCO classification with the TOAST classification in a population with acute ischemic stroke. J Neurol (2011) 0.81
Asymptomatic and symptomatic carotid stenosis: an obsolete classification? Stroke Res Treat (2012) 0.81
Design, data management, and population baseline characteristics of the PERFORM magnetic resonance imaging project. J Neurol (2010) 0.79
Women have a poorer very long-term functional outcome after stroke among adults aged 18-50 years: the FUTURE study. J Neurol (2016) 0.77
Observational Dutch Young Symptomatic StrokE studY (ODYSSEY): study rationale and protocol of a multicentre prospective cohort study. BMC Neurol (2014) 0.77
Rationale, design and population baseline characteristics of the PERFORM vascular project: an ancillary study of the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) trial. Cardiovasc Drugs Ther (2010) 0.76
Accelerated development of cerebral small vessel disease in young stroke patients. Neurology (2016) 0.75
Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention. J Cell Mol Med (2010) 0.75
High incidence of diabetes after stroke in young adults and risk of recurrent vascular events: the FUTURE study. PLoS One (2014) 0.75
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
Biochemical detection of left-ventricular systolic dysfunction. Lancet (1998) 7.51
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J (2005) 5.40
Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis (2006) 5.20
Outcome of survivors of accidental deep hypothermia and circulatory arrest treated with extracorporeal blood warming. N Engl J Med (1997) 5.00
Termination of trial of streptokinase in severe acute ischaemic stroke. MAST Study Group. Lancet (1995) 4.50
Randomised controlled trial of specialist nurse intervention in heart failure. BMJ (2001) 4.43
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (1999) 4.36
Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study. Circulation (2001) 4.32
Effect of socioeconomic deprivation on waiting time for cardiac surgery: retrospective cohort study. BMJ (2000) 4.21
General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet (2008) 4.18
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. Neurology (2008) 4.07
Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. N Engl J Med (2000) 3.90
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke (2000) 3.74
Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet (1997) 3.70
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology (2007) 3.56
Nonparametric analysis of statistic images from functional mapping experiments. J Cereb Blood Flow Metab (1996) 3.44
Very early risk of stroke after a first transient ischemic attack. Stroke (2003) 3.26
Diffuse axonal injury in head injury: definition, diagnosis and grading. Histopathology (1989) 3.24
Mannheim intima-media thickness consensus. Cerebrovasc Dis (2004) 3.05
Effect of reducing ambulance response times on deaths from out of hospital cardiac arrest: cohort study. BMJ (2001) 2.85
Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes. Int J Clin Pract (2010) 2.75
Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J (1985) 2.74
Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology (2005) 2.69
Flow of excitation within rat barrel cortex on striking a single vibrissa. J Neurophysiol (1992) 2.63
Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: a multicenter study. Neurology (2011) 2.62
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation (1999) 2.59
Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation (2006) 2.53
Psychiatric morbidity and compulsory admission among UK-born Europeans, Afro-Caribbeans and Asians in central Manchester. Br J Psychiatry (1993) 2.52
Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet (2004) 2.51
The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin. BMJ (1997) 2.44
The problem of associating coagulase-negative staphylococci with disease. Ann N Y Acad Sci (1965) 2.43
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart (2007) 2.40
Human calcitonin in the treatment of Paget's bone disease. Lancet (1971) 2.37
Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology (2004) 2.36
Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review. Neurology (2010) 2.34
Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med (2003) 2.30
Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle. Circulation (1998) 2.26
Detection of diabetic macular edema. Ophthalmoscopy versus photography--Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group. Ophthalmology (1989) 2.24
Myocardial ischaemia in patients with frequent angina pectoris. Br Med J (1978) 2.22
The AKT kinase is activated in multiple myeloma tumor cells. Blood (2001) 2.20
The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk. Am J Cardiol (1999) 2.18
The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys (1994) 2.17
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet (2011) 2.16
Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology (2002) 2.16
Severe hypotension after first dose of enalapril in heart failure. Br Med J (Clin Res Ed) (1985) 2.14
Time course of symptoms in extracranial carotid artery dissections. A series of 80 patients. Stroke (1995) 2.13
Combination therapy with clopidogrel and aspirin: can the CURE results be extrapolated to cerebrovascula patients? Stroke (2001) 2.13
Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science (1985) 2.10
Spatiotemporal convergence and divergence in the rat S1 "barrel" cortex. J Comp Neurol (1987) 2.10
Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis. Ann Intern Med (1990) 2.09
Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology (2004) 2.09
Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies. Stroke (2004) 2.08
Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are needed. J Clin Epidemiol (2010) 2.08
Incidence and prognosis of > or = 50% symptomatic vertebral or basilar artery stenosis: prospective population-based study. Brain (2009) 2.08
American Academy of Pediatrics. Committee on Adolescence. Contraception in adolescents. Pediatrics (1999) 2.06
Is alignment within 8 prism diopters of orthotropia a successful outcome for infantile esotropia surgery? Arch Ophthalmol (1996) 2.06
Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol (2007) 2.02
Postsynaptic control of plasticity in developing somatosensory cortex. Nature (1993) 2.01
Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol (1998) 2.00
Direct assessment of completeness of ascertainment in a stroke incidence study. Stroke (2004) 1.99
Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project. Eur Heart J (2002) 1.98
Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients. Neurology (2009) 1.98
Detection of ambulatory ischaemia is not of practical clinical value in the routine management of patients with stable angina. A long-term follow-up study. Eur Heart J (1995) 1.97
Should baseline PSA testing be performed in men aged 40 to detect those aged 50 or less who are at risk of aggressive prostate cancer? S Afr Med J (2011) 1.95
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun (2000) 1.93
Assessment of health needs and willingness to utilize health care resources of adolescents in a suburban population. J Pediatr (1983) 1.90
Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry (2004) 1.90
Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study. Lancet (2001) 1.90
Interaction between cigarettes and propranolol in treatment of angina pectoris. Br Med J (1980) 1.89
Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol (1998) 1.88
Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke (1996) 1.86
Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res (1991) 1.86
The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J (2004) 1.84
Peduncular 'rubral' tremor and dopaminergic denervation: a PET study. Neurology (1995) 1.84
Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry (2003) 1.84
Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure. Am J Med (1984) 1.83
Is calcium the clue? Eur Heart J (2002) 1.81
Sexually transmitted diseases in the People's Republic of China in Y2K: back to the future. Sex Transm Dis (2000) 1.80
Systematic review of the risks of carotid endarterectomy in relation to the clinical indication for and timing of surgery. Stroke (2003) 1.79
The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry (2003) 1.78
Classification of stroke subtypes. Cerebrovasc Dis (2009) 1.78
Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart (2001) 1.77
Trial of Whooping-cough Vaccine. Br Med J (1945) 1.76
Critical period for monocular deprivation in the cat visual cortex. J Neurophysiol (1992) 1.75